©2024 Stanford Medicine
Pain Catastrophizing and Prescription Opioid Craving
Recruiting
I'm InterestedTrial ID: NCT04097743
Purpose
Adherence to prescription opioid and opioid tapering as indicated are critical for safe
chronic opioid therapy for chronic pain, but this can be difficult for patients experiencing
prescription opioid craving. Because pain catastrophizing is proposed as a possible treatment
target by our and others' preliminary results, the proposed study aims to determine whether
pain catastrophizing is a treatment target to reduce prescription opioid craving and to
investigate whether negative affect and stress hormones are potential mediators. The findings
from the current study will inform whether a psychology intervention to lower pain
catastrophizing will reduce opioid craving, and whether psychological and physical distress
as well as cognitive function will be potential mediators of the treatment effect.
Official Title
Effect of Pain Catastrophizing on Prescription Opioid Craving
Stanford Investigator(s)
Dokyoung Sophia You, PhD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
- At least 18 years
- Chronic pain ( > 3months)
- Prescription opioid use (>3 months)
Exclusion Criteria:
- Current diagnosis of cancer
- Concurrent psychological therapy
- Other severe psychiatric conditions (schizophrenia, delusional disorder, psychotic
disorder, dissociative disorder, and active suicidality)
- Any skin conditions on the hand (pain testing site)
- Non-English speaker
- No access to email or smart phone
Intervention(s):
behavioral: Coping Statement
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
SNAPL lab
650-723-8346